Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

Isabelle C. Van Gelder*, Jeff S. Healey, Harry J. G. M. Crijns, Jia Wang, Stefan H. Hohnloser, Michael R. Gold, Alessandro Capucci, Chu-Pak Lau, Carlos A. Morillo, Anne H. Hobbelt, Michiel Rienstra, Stuart J. Connolly

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1339-1344
Number of pages6
JournalEuropean Heart Journal
Volume38
Issue number17
DOIs
Publication statusPublished - 1 May 2017

Keywords

  • TEMPORAL RELATIONSHIP
  • EMBOLIC EVENTS
  • PROGRESSION
  • RISK
  • REGISTRY
  • RHYTHM
  • PROGNOSIS
  • COHORT
  • TRIAL
  • MORTALITY

Cite this

Van Gelder, I. C., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., Capucci, A., Lau, C-P., Morillo, C. A., Hobbelt, A. H., Rienstra, M., & Connolly, S. J. (2017). Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. European Heart Journal, 38(17), 1339-1344. https://doi.org/10.1093/eurheartj/ehx042